ORAL FORMULATION TABLETS & CAPSULES
CordenPharma’s service offerings include a wide range of products, formulations and services supporting new chemical entities, re-formulations and generics:
- >> Powder & Granule-filled Capsules
- >> Powder Granules & Pellets
- >> Immediate Release Tablets
- >> Controlled Release Tablets
- >> Mini-tablets
- >> Multi-layer Tablets
- >> Blister & Bottle Packaging
Drug Products for Pediatric use:
- >> Mini-tablets
- >> Granules & Pellets
- >> Dry Syrup
- >> Oral Disintegrating Tablets (ODT)
- >> Small Chewable Tablets or Effervescent Tablets
- >> Small Standard Tablets & Capsules (low dose)
- >> Taste Masking
In addition, high shear granulation and fluid bed granulation with aqueous or organic solvents are available.
CordenPharma can develop and manufacture from hundreds of grams to commercial-scale manufacturing.
Highly Potent & Oncology Formulation
CordenPharma is the partner of choice in the area of Highly Potent and Oncology Formulations. From small scale development quantities to commercialization, we offer a continuum of services including a variety of capabilities in finished dose manufacturing and packaging.
Highly Potent and oncological products present challenges due to the complex handling. Our facilities are designed to meet the strictest regulatory and safety standards to ensure the safety of production personnel and the environment while maintaining the integrity of the product. We utilize a proven management system, engineering controls, occupational health pre-planning and protective equipment for a wide range of products and safety classifications.
Our key expertise in highly potent and oncological manufacturing along with a long-standing reputation of quality and reliability in all regulated markets including Japan make CordenPharma the partner of choice.
CordenPharma’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs), Finished Dosage and Packaging in our network of facilities allows clients full access to integrated services resulting in a simplified supply chain, reduced risk and cost associated with technology transfers, and ultimately faster production and delivery timelines.